Latebreakers: CMS clarifies National Provider Identifier (NPI) rule as deadline looms

The lawsuit alleges that the company knowingly violated both the Controlled Substances Act and the False Claims Act.

Todd Eury of the Pharmacy Podcast Network is joined by Josh Bolin of the NABP to talk about DSCSA, what benefits it will provide, and how to make sure your pharmacy is ready when it goes into effect this November.

Benjamin Jolley, PharmD, pharmacist at Jolley’s Compounding Pharmacy in Salt Lake City, Utah, discussed the state of independent pharmacy.

Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.

PBM reform legislation has progressed further in Congress than ever before.

On October 3,2024, Texas Attorney General Ken Paxton issued the lawsuit, which involves Eli Lilly, Express Scripts, CVS Pharmacy, and other pharmaceutical entities.